BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

867 related articles for article (PubMed ID: 28781282)

  • 1. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.
    Shono Y; Docampo MD; Peled JU; Perobelli SM; Velardi E; Tsai JJ; Slingerland AE; Smith OM; Young LF; Gupta J; Lieberman SR; Jay HV; Ahr KF; Porosnicu Rodriguez KA; Xu K; Calarfiore M; Poeck H; Caballero S; Devlin SM; Rapaport F; Dudakov JA; Hanash AM; Gyurkocza B; Murphy GF; Gomes C; Liu C; Moss EL; Falconer SB; Bhatt AS; Taur Y; Pamer EG; van den Brink MRM; Jenq RR
    Sci Transl Med; 2016 May; 8(339):339ra71. PubMed ID: 27194729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease.
    Lee SE; Lim JY; Ryu DB; Kim TW; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Kim CS; Shin DM; Min CK
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):1933-1943. PubMed ID: 31195137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation.
    Khuat LT; Le CT; Pai CS; Shields-Cutler RR; Holtan SG; Rashidi A; Parker SL; Knights D; Luna JI; Dunai C; Wang Z; Sturgill IR; Stoffel KM; Merleev AA; More SK; Maverakis E; Raybould HE; Chen M; Canter RJ; Monjazeb AM; Dave M; Ferrara JLM; Levine JE; Longo DL; Abedi M; Blazar BR; Murphy WJ
    Sci Transl Med; 2020 Nov; 12(571):. PubMed ID: 33239390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation.
    Hidaka D; Hayase E; Shiratori S; Hasegawa Y; Ishio T; Tateno T; Okada K; Goto H; Sugita J; Onozawa M; Nakagawa M; Kahata K; Endo T; Hashimoto D; Teshima T
    Clin Transplant; 2018 Sep; 32(9):e13361. PubMed ID: 30054935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiome and diversity indices during blood stem cells transplantation - new perspectives?
    Parco S; Benericetti G; Vascotto F; Palmisciano G
    Cent Eur J Public Health; 2019 Dec; 27(4):335-339. PubMed ID: 31951695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
    Tanaka JS; Young RR; Heston SM; Jenkins K; Spees LP; Sung AD; Corbet K; Thompson JC; Bohannon L; Martin PL; Stokhuyzen A; Vinesett R; Ward DV; Bhattarai SK; Bucci V; Arshad M; Seed PC; Kelly MS
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2053-2060. PubMed ID: 32682948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.
    Shono Y; van den Brink MRM
    Nat Rev Cancer; 2018 May; 18(5):283-295. PubMed ID: 29449660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation.
    Doki N; Suyama M; Sasajima S; Ota J; Igarashi A; Mimura I; Morita H; Fujioka Y; Sugiyama D; Nishikawa H; Shimazu Y; Suda W; Takeshita K; Atarashi K; Hattori M; Sato E; Watakabe-Inamoto K; Yoshioka K; Najima Y; Kobayashi T; Kakihana K; Takahashi N; Sakamaki H; Honda K; Ohashi K
    Ann Hematol; 2017 Sep; 96(9):1517-1523. PubMed ID: 28733895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients.
    Simms-Waldrip TR; Sunkersett G; Coughlin LA; Savani MR; Arana C; Kim J; Kim M; Zhan X; Greenberg DE; Xie Y; Davies SM; Koh AY
    Biol Blood Marrow Transplant; 2017 May; 23(5):820-829. PubMed ID: 28192251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detrimental Effect of Broad-spectrum Antibiotics on Intestinal Microbiome Diversity in Patients After Allogeneic Stem Cell Transplantation: Lack of Commensal Sparing Antibiotics.
    Weber D; Hiergeist A; Weber M; Dettmer K; Wolff D; Hahn J; Herr W; Gessner A; Holler E
    Clin Infect Dis; 2019 Apr; 68(8):1303-1310. PubMed ID: 30124813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic Acid Signaling Modulates Recipient Gut Barrier Integrity and Microbiota After Allogeneic Hematopoietic Stem Cell Transplantation in Mice.
    Pan P; Atkinson SN; Taylor B; Zhu H; Zhou D; Flejsierowicz P; Wang LS; Morse M; Liu C; Gunsolus IL; Chen X
    Front Immunol; 2021; 12():749002. PubMed ID: 34759928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-
    Heidrich V; Bruno JS; Knebel FH; de Molla VC; Miranda-Silva W; Asprino PF; Tucunduva L; Rocha V; Novis Y; Arrais-Rodrigues C; Fregnani ER; Camargo AA
    Front Immunol; 2021; 12():692225. PubMed ID: 34220852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
    Ingham AC; Kielsen K; Mordhorst H; Ifversen M; Aarestrup FM; Müller KG; Pamp SJ
    Microbiome; 2021 Jun; 9(1):148. PubMed ID: 34183060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease.
    Sugio T; Kato K; Aoki T; Ohta T; Saito N; Yoshida S; Kawano I; Henzan H; Kadowaki M; Takase K; Muta T; Miyawaki K; Yamauchi T; Shima T; Takashima S; Mori Y; Yoshimoto G; Kamezaki K; Takenaka K; Iwasaki H; Ogawa R; Ohno Y; Eto T; Kamimura T; Miyamoto T; Akashi K
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1608-1614. PubMed ID: 27220263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease.
    Hayase E; Hayase T; Jamal MA; Miyama T; Chang CC; Ortega MR; Ahmed SS; Karmouch JL; Sanchez CA; Brown AN; El-Himri RK; Flores II; McDaniel LK; Pham D; Halsey T; Frenk AC; Chapa VA; Heckel BE; Jin Y; Tsai WB; Prasad R; Tan L; Veillon L; Ajami NJ; Wargo JA; Galloway-Peña J; Shelburne S; Chemaly RF; Davey L; Glowacki RWP; Liu C; Rondon G; Alousi AM; Molldrem JJ; Champlin RE; Shpall EJ; Valdivia RH; Martens EC; Lorenzi PL; Jenq RR
    Cell; 2022 Sep; 185(20):3705-3719.e14. PubMed ID: 36179667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal microbiota-related effects on graft-versus-host disease.
    Shono Y; Docampo MD; Peled JU; Perobelli SM; Jenq RR
    Int J Hematol; 2015 May; 101(5):428-37. PubMed ID: 25812838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
    Modi A; Rybicki L; Majhail NS; Mossad SB
    Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
    Kumari R; Palaniyandi S; Hildebrandt GC
    Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.